Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers

Glucocorticoids (GC) induce cardiometabolic risk while atherosclerosis is a chronic inflammation involving immunity. GC are immune suppressors, and the adrenocorticotrophic hormone (ACTH) has immune modulator activities. Both may act in atherothrombotic inflammation involving immune cells (IMNC). Ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Gloria Aranda, Cristina Lopez, Rebeca Fernandez-Ruiz, Yaiza Esteban, Guillermo Garcia-Eguren, Mireia Mora, Irene Halperin, Gregori Casals, Joaquim Enseñat, Felicia A. Hanzu
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2017/2912763
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552325817827328
author Gloria Aranda
Cristina Lopez
Rebeca Fernandez-Ruiz
Yaiza Esteban
Guillermo Garcia-Eguren
Mireia Mora
Irene Halperin
Gregori Casals
Joaquim Enseñat
Felicia A. Hanzu
author_facet Gloria Aranda
Cristina Lopez
Rebeca Fernandez-Ruiz
Yaiza Esteban
Guillermo Garcia-Eguren
Mireia Mora
Irene Halperin
Gregori Casals
Joaquim Enseñat
Felicia A. Hanzu
author_sort Gloria Aranda
collection DOAJ
description Glucocorticoids (GC) induce cardiometabolic risk while atherosclerosis is a chronic inflammation involving immunity. GC are immune suppressors, and the adrenocorticotrophic hormone (ACTH) has immune modulator activities. Both may act in atherothrombotic inflammation involving immune cells (IMNC). Aim. To investigate adhesion and activation surface cell markers (CDs) of peripheral IMNC in endogenous Cushing syndrome (CS) and the immune modulator role of ACTH. Material and Methods. 16 ACTH-dependent CS (ACTH-D), 10 ACTH-independent (ACTH-ID) CS, and 16 healthy controls (C) were included. Leukocytes (Leuc), monocytes (MN), lymphocytes (Lym), and neutrophils (N) were analyzed by flow cytometry for atherosclerosis previously associated with CDs. Results. Leuc, N, and MN correlated with CS (p<0.05), WC (p<0.001), WHR (p=0.003), BMI (p<0.001), and hs-CRP (p<0.001). CD14++CD16+ (p=0.047); CD14+CD16++ (p=0.053) MN; CD15+ (p=0.027); CD15+CD16+ (p=0.008) N; and NK-Lym (p=0.019) were higher in CS. CD14+CD16++ MN were higher in ACTH-ID (8.9 ± 3.5%) versus ACTH-D CS (4.2 ± 1.9%) versus C (4.9 ± 2.3%). NK-Lym correlated with c-LDL (r = 0.433, p=0.039) and CD15+ N with hs-CRP (r = 0.446, p=0.037). In multivariate analysis, Leuc, N, and MN depended on BMI (p=0.021), WC (p=0.002), and WHR (p=0.014), while CD15+ and CD15+CD16+ N on hypercortisolism and CS (p=0.035). Conclusion. In CS, IMNC present changes in activation and adhesion CDs implicated in atherothrombotic inflammation. ACTH-IDCS presents a particular IMNC phenotype, possibly due to the absence of the immune modulator effect of ACTH.
format Article
id doaj-art-d4213fd57ac5495fa0fcc5ec7017e3be
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-d4213fd57ac5495fa0fcc5ec7017e3be2025-02-03T05:58:57ZengWileyInternational Journal of Endocrinology1687-83371687-83452017-01-01201710.1155/2017/29127632912763Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface MarkersGloria Aranda0Cristina Lopez1Rebeca Fernandez-Ruiz2Yaiza Esteban3Guillermo Garcia-Eguren4Mireia Mora5Irene Halperin6Gregori Casals7Joaquim Enseñat8Felicia A. Hanzu9Group of Endocrine Disorders, IDIBAPS, Barcelona, SpainCytometry Department, IDIBAPS, Barcelona, SpainCentro de Investigación en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, SpainCentro de Investigación en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, SpainGroup of Endocrine Disorders, IDIBAPS, Barcelona, SpainGroup of Endocrine Disorders, IDIBAPS, Barcelona, SpainGroup of Endocrine Disorders, IDIBAPS, Barcelona, SpainBiochemistry and Molecular Genetics Service, Hospital Clinic Universitari and IDIBAPS and CIBERehd, Barcelona, SpainUniversity of Barcelona, Barcelona, SpainGroup of Endocrine Disorders, IDIBAPS, Barcelona, SpainGlucocorticoids (GC) induce cardiometabolic risk while atherosclerosis is a chronic inflammation involving immunity. GC are immune suppressors, and the adrenocorticotrophic hormone (ACTH) has immune modulator activities. Both may act in atherothrombotic inflammation involving immune cells (IMNC). Aim. To investigate adhesion and activation surface cell markers (CDs) of peripheral IMNC in endogenous Cushing syndrome (CS) and the immune modulator role of ACTH. Material and Methods. 16 ACTH-dependent CS (ACTH-D), 10 ACTH-independent (ACTH-ID) CS, and 16 healthy controls (C) were included. Leukocytes (Leuc), monocytes (MN), lymphocytes (Lym), and neutrophils (N) were analyzed by flow cytometry for atherosclerosis previously associated with CDs. Results. Leuc, N, and MN correlated with CS (p<0.05), WC (p<0.001), WHR (p=0.003), BMI (p<0.001), and hs-CRP (p<0.001). CD14++CD16+ (p=0.047); CD14+CD16++ (p=0.053) MN; CD15+ (p=0.027); CD15+CD16+ (p=0.008) N; and NK-Lym (p=0.019) were higher in CS. CD14+CD16++ MN were higher in ACTH-ID (8.9 ± 3.5%) versus ACTH-D CS (4.2 ± 1.9%) versus C (4.9 ± 2.3%). NK-Lym correlated with c-LDL (r = 0.433, p=0.039) and CD15+ N with hs-CRP (r = 0.446, p=0.037). In multivariate analysis, Leuc, N, and MN depended on BMI (p=0.021), WC (p=0.002), and WHR (p=0.014), while CD15+ and CD15+CD16+ N on hypercortisolism and CS (p=0.035). Conclusion. In CS, IMNC present changes in activation and adhesion CDs implicated in atherothrombotic inflammation. ACTH-IDCS presents a particular IMNC phenotype, possibly due to the absence of the immune modulator effect of ACTH.http://dx.doi.org/10.1155/2017/2912763
spellingShingle Gloria Aranda
Cristina Lopez
Rebeca Fernandez-Ruiz
Yaiza Esteban
Guillermo Garcia-Eguren
Mireia Mora
Irene Halperin
Gregori Casals
Joaquim Enseñat
Felicia A. Hanzu
Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
International Journal of Endocrinology
title Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
title_full Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
title_fullStr Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
title_full_unstemmed Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
title_short Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
title_sort circulatory immune cells in cushing syndrome bystanders or active contributors to atherometabolic injury a study of adhesion and activation of cell surface markers
url http://dx.doi.org/10.1155/2017/2912763
work_keys_str_mv AT gloriaaranda circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT cristinalopez circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT rebecafernandezruiz circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT yaizaesteban circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT guillermogarciaeguren circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT mireiamora circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT irenehalperin circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT gregoricasals circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT joaquimensenat circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers
AT feliciaahanzu circulatoryimmunecellsincushingsyndromebystandersoractivecontributorstoatherometabolicinjuryastudyofadhesionandactivationofcellsurfacemarkers